ARK Genomic Valuation
| ARKG Etf | USD 23.32 0.46 2.01% |
At this time, the entity appears to be overvalued. ARK Genomic Revolution shows a prevailing Real Value of $22.0 per share. The current price of the entity is $23.32. Our model approximates the value of ARK Genomic Revolution from reviewing the entity fundamentals such as Price To Sales of 7.63 X, number of employees of 330, and Price To Earning of 41.86 X as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ARK Genomic's price fluctuation is not too volatile at this time. Calculation of the real value of ARK Genomic Revolution is based on 3 months time horizon. Increasing ARK Genomic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ARK etf is determined by what a typical buyer is willing to pay for full or partial control of ARK Genomic Revolution. Since ARK Genomic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ARK Etf. However, ARK Genomic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.32 | Real 22.0 | Hype 23.32 | Naive 25.37 |
The real value of ARK Etf, also known as its intrinsic value, is the underlying worth of ARK Genomic Revolution ETF, which is reflected in its stock price. It is based on ARK Genomic's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ARK Genomic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ARK Genomic Revolution helps investors to forecast how ARK etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ARK Genomic more accurately as focusing exclusively on ARK Genomic's fundamentals will not take into account other important factors: Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ARK Genomic's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ARK Genomic and how it compares across the competition.
About ARK Genomic Valuation
The etf valuation mechanism determines ARK Genomic's current worth on a weekly basis. Our valuation model uses a comparative analysis of ARK Genomic. We calculate exposure to ARK Genomic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ARK Genomic's related companies.The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution . Ark Genomic is traded on BATS Exchange in the United States.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ARK Genomic Revolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.